Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 12.74
-0.51 (-3.85%)
Jun 19, 2026, 4:11 PM AEST
Neuren Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Neuren Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $23.45. The average 1-year stock price forecast is 84.07% higher than the current stock price, while the lowest is $18.60 (+46.00%) and the highest is $29.00 (+127.63%).
Price Target: $23.45 (+84.07%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 19, 2026.
Analyst Ratings
The average analyst rating for Neuren Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $24.00 | Buy | Maintains | $24.00 | +88.38% | May 19, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $22.00 | Buy | Maintains | $22.00 | +72.68% | May 9, 2026 |
| Macquarie | Macquarie | Buy Maintains $19.10 | Buy | Maintains | $19.10 | +49.92% | Mar 3, 2026 |
| Jefferies | Jefferies | Buy Maintains $27.00 | Buy | Maintains | $27.00 | +111.93% | Feb 6, 2026 |
| Petra Capital | Petra Capital | Buy Maintains $29.96 | Buy | Maintains | $29.96 | +135.16% | Feb 5, 2026 |
Financial Forecast
Revenue This Year
74.19M
from 64.65M
Increased by 14.75%
Revenue Next Year
147.32M
from 74.19M
Increased by 98.59%
EPS This Year
0.09
from 0.23
Decreased by -59.59%
EPS Next Year
0.49
from 0.09
Increased by 425.04%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 84.4M | ||
| Avg | 74.2M | ||
| Low | 70.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.6% | ||
| Avg | 14.8% | ||
| Low | 8.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.19 | ||
| Avg | 0.09 | ||
| Low | -0.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -16.6% | ||
| Avg | -59.6% | ||
| Low | - |